Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir. Influence on Metabolic Abnormalities

NCT00139178 is registered in ClinicalTrials.gov with Danish HIV Research Group as lead sponsor.

NCT NCT00139178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00139178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir. Influence on Metabolic Abnormalities
Lead sponsor
Danish HIV Research Group
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2004
Completion date
April 30, 2007
Enrollment
100
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, hiv associated lipodystrophy syndrome., hypercholesterolemia, lipoatrophy